Skip to main content
Joshua Reuss, MD, Oncology, Washington, DC

Joshua Eric Reuss MD


Physician

Join to View Full Profile
  • 3800 Reservoir RdWashington, DC 20007

  • Phone+1 202-444-2223

Dr. Reuss is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Virginia Medical Center
    University of Virginia Medical CenterResidency, Internal Medicine, 2014 - 2017
  • University of Rochester School of Medicine and Dentistry
    University of Rochester School of Medicine and DentistryClass of 2014

Certifications & Licensure

  • DC State Medical License
    DC State Medical License 2020 - 2026
  • MD State Medical License
    MD State Medical License 2017 - 2025
  • VA State Medical License
    VA State Medical License 2014 - 2017
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Immune-Related (IR)-Pneumonitis During the COVID-19 Pandemic: Multidisciplinary Recommendations for Diagnosis and Management  
    Joshua E Reuss, Karthik Suresh, David Feller-Kopman, Clare Rock, Julie R Brahmer, Journal For Immunotherapy of Cancer

Lectures

  • Neoadjuvant nivolumab in resectable non-small cell lung cancer: Extended follow-up and molecular markers of response. 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/2/2019

Press Mentions

  • The Evidence Gap: Immunotherapy Timing in Early-Stage NSCLC?
    The Evidence Gap: Immunotherapy Timing in Early-Stage NSCLC?December 23rd, 2024
  • Investigational Drug Shows Promise in a Clinical Trial for Lung Cancers with ALK Mutations
    Investigational Drug Shows Promise in a Clinical Trial for Lung Cancers with ALK MutationsNovember 8th, 2024

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: